ArticleRSC advances2022

Two-stage one-pot synthetic strategy for the key triazone-triazole intermediate of ensitrelvir (S-217622), an oral clinical candidate for treating COVID-19.

Wei Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.